Recognition of a Biological Substance as a “New Substance” Despite the Absence of Differences in the Primary and Secondary Structure of the Protein Compared to a Previously Registered Substance. A recent decision[1] by the Israel Patent...
In a Nutshell In Unipharm v. Sanofi,[1] the Supreme Court accepted Unipharm’s claim for the restitution of profits derived by Sanofi in consequence of filing a patent application for a polymorph of an active ingredient of a drug that was...
A new regulatory scheme for pharmaceuticals was established in Israel. The scheme establishes a new regulatory pathway of temporary approvals for the importation and supply of pharmaceuticals during the time of the pendency of the marketing...
In December 2023, Israel’s Ministry of Health (“MoH”) published substantial revisions to the guidelines regulating policy and procedure for the registration and use of biosimilar pharmaceuticals in Israel (Procedure No. 127). The new guidelines...
We feel very proud and thankful to mark 90 years of the Reinhold Cohn Group. In May of 1934, Dr. Reinhold Cohn, a German Jewish patent attorney who had to flee from the Nazi regime, arrived in Tel Aviv and opened a small office. In those days industry was scarce, and the universities were still
This article was included in the AIPPI Congress News and explains the significance of the AIPPI Resolution on “Experimental Use and Bolar-type Exemptions to Patent Infringement,”, which plays an important role in pursuing global and...
Dear friends, We thank the hundreds of clients and colleagues from all over the world for their words of support and encouragement and for expressing their shock and feelings of abhorrence, pursuant to the atrocities committed by Hamas against civilians, including babies, toddlers, women, and men,...
Ten prominent fragrance companies, including Armani, Chloe, Davidoff, Hugo Boss, Lancôme, L’Oréal, Polo, and more, recently took an Israeli ‘smell-alike’ perfume maker to court over trademark infringement. The Israeli court...